Other cancers with amplified LYPLA1 include metastatic prostate adenocarcinoma, ovarian serous cystadenocarcinoma, and uveal melanoma (Beltran et al., 2016; Cancer Genome Atlas Research Network et al., 2013, and Eirew et al., 2015). Here, LYPLA1 is linked to ovarian serous cystadenocarcinoma.